viewCello Health PLC

Cello Health PLC - Block listing Interim Review

RNS Number : 1647A
Cello Health PLC
24 May 2019

24 May 2019

Cello Health plc

("Cello" or the "Company")

Additional Block Listing of Ordinary Shares

Block Listing Update


The Company announces that an application has been made to the London Stock Exchange for a block admission for 2,368,200 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.


These new Ordinary Shares will be issued and allotted from time to time pursuant to the exercise of existing options under the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010. The new Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company. Admission of the new Ordinary Shares is expected to occur on 31 May 2019.


Further to the announcement by the Company on 14 December 2018, the Company also announces that a total of 61,061 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted since that date (pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing applied for at that time (the "Block Listing"). An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.




Cello Health

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Group Finance Director

Cenkos Securities

  020 7397 8900

Mark Connelly

Harry Hargreaves


  020 7466 5000

Mark Court

Jamie Hooper

Sophie Wills




Name of applicant:

Cello Health plc

Name of scheme:

PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010

Period of return:


31 November 2018


23 May 2019

Balance of unallotted securities under scheme(s) from previous return:


Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):


Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):


Equals:  Balance under scheme(s) not yet issued/allotted at end of period:


Name of contact:

Mark Bentley, Group Finance Director

Telephone number of contact:

020 7812 8460



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Cello Health PLC

Price: -

Market: AIM
Market Cap: -

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Market Report: FTSE lacks direction as investors await next big market mover

The London bourse is slightly lower this Wednesday with US data pointing towards a potentially painful recession. More doom for the tourism industry following the news Princess Cruises (LON:CLL) said it would cancel early 2021 cruises on two ships due to the COVID-19 pandemic...

3 weeks, 3 days ago